Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only

Who May Qualify: - Patient is indicated for total ankle arthroplasty - Patient is skeletally mature - Patient is mentally capable of completing follow-up forms - Patient will be available for follow-up out to 10 years - Patient has been deemed a candidate for Ankle replacement by diagnosis of the investigator - Patient is willing and able to read and sign a study willing to sign a consent form form Who Should NOT Join This Trial: - Patient with excessive bone loss at the ankle joint site - Patient with severe osteoporosis - Patient with complete talar avascular necrosis - Patient with Active Osteomyelitis - Patient with Infection at the ankle site or infection at distant sites that could migrate to the ankle - Patient with Sepsis - Patient with Vascular deficiency in the involved limb - Patient with Neuromuscular inadequacy (e.g. Prior paralysis, fusion and or inadequate abductor strength) - Patient with Neuropathic joints - Patient with Neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing - Patient with Poor soft tissue coverage around the ankle - Patient with Charcot arthropathy - Previous ankle arthrodesis with excision of the malleoli - Excessive loads as caused by activity or patient weight - per investigator discretion - Skeletally immature patients (patient is less than 21 years if age at time of surgery) - Patient with dementia - Patient with known metal allergies - Patient who is pregnant Always talk to your doctor about whether this trial is right for you.